Shalini Shah, MD
Pain Medicine · Orange, CANPI 1932386166
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Masimo Corporation at 34.7% of the total. Reporting peaked in 2020 at $63,883 and has fallen 70.8% since, to $18,639 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $832.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Masimo Corporation$49K
- SPR Therapeutics, Inc$46K
- AbbVie$23K
- Vertex$17K
- GRT US Holding, Inc.$5K
- Medtronic$337
- plus $378 from 4 others
Across 1 payment — averaging $614.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$615
What the payments were for
- Consulting fees$82,40059%
- Speaking & faculty fees$40,24829%
- Travel & lodging$7,1555%
- Food & beverage$10,7818%
- Education$770%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Masimo Corporation | 56 | $48,750 |
| SPR Therapeutics, Inc | 38 | $46,193 |
| AbbVie(2 entities) | 37 | $23,167 |
| Vertex | 25 | $17,043 |
| GRT US Holding, Inc. | 6 | $4,791 |
| Medtronic | 2 | $337 |
| Orthofix Medical, Inc. | 1 | $177 |
| Boston Scientific | 1 | $130 |
| Teleflex LLC | 1 | $36 |
| Trevena, Inc. | 2 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$45,678
- Patient SafetyNet System$39,375
- JOURNAVX$16,619
- BOTOX$12,670
- UBRELVY$10,028
- Qutenza$4,678
- SET and rainbow SET$3,750
- Spinal-Stim$177
- INTELLIS ADAPTIVESTIM$169
- MAZOR X SYSTEM$168
- GENERAL PAIN MANAGEMENT$130
How this compares
$140,660 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $618 |
| Celecoxib | 17 | $421 |
| Gabapentin | 12 | $162 |
| Methadone Hcl | 11 | $134 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Orange
- Brian BoydOrange$127K
- Eric ChangOrange$27K
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.